0001533914-20-000002.txt : 20200415
0001533914-20-000002.hdr.sgml : 20200415
20200415103700
ACCESSION NUMBER: 0001533914-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200415
DATE AS OF CHANGE: 20200415
EFFECTIVENESS DATE: 20200415
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: OnKure, Inc.
CENTRAL INDEX KEY: 0001533914
IRS NUMBER: 451451149
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-365012
FILM NUMBER: 20792924
BUSINESS ADDRESS:
STREET 1: 1105 SPRUCE STREET
CITY: BOULDER
STATE: CO
ZIP: 80302
BUSINESS PHONE: 720 307 2892
MAIL ADDRESS:
STREET 1: 1105 SPRUCE STREET
CITY: BOULDER
STATE: CO
ZIP: 80302
D
1
primary_doc.xml
X0708
D
LIVE
0001533914
OnKure, Inc.
1105 SPRUCE STREET
BOULDER
CO
COLORADO
80302
720 307 2892
DELAWARE
None
None
Corporation
true
Anthony
D.
Piscopio
c/o OnKure, Inc.
1105 Spruce Street
Boulder
CO
COLORADO
80302
Executive Officer
Director
Xuedong
Liu
7007 Johnson Circle
Niwot
CO
COLORADO
80503
Executive Officer
Director
Donna
Peak
2 Longfellow Lane
Houston
TX
TEXAS
77005
Director
Zhao
Guobao
Suite 1907, Office Tower El, Oriental
Plaza, No. 1, East Chang Ave, Dong Cheng
Beijing
F4
CHINA
100738
Director
Keith
Michael
Olivia
c/o OnKure, Inc.
1105 Spruce Street
Boulder
CO
COLORADO
80302
Executive Officer
John
DeMattei
c/o OnKure, Inc.
1105 Spruce Street
Boulder
CO
COLORADO
80302
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-04-15
false
true
true
true
Series A-1 Preferred Stock, Common Stock and Warrants to purchase Series A-1 Preferred Stock
false
12148
5236935
3236935
2000000
The total offering amount includes the cumulative exercise price of $2,000,000 for Warrants to purchase 928,820 shares of Series A-1 Preferred Stock.
false
6
0
0
0
false
OnKure, Inc.
Keith M. Olivia
Keith M. Olivia
General Counsel
2020-04-15